Do COPD subtypes really exist? COPD heterogeneity and clustering in 10 independent cohorts

Thorax

Volumn 72, Issue 11, 2017, Pages 998-1006

  Castaldi, Peter J ^a   Benet, Marta ^b,c,d   Petersen, Hans ^e   Rafaels, Nicholas ^f   Finigan, James ^g   Paoletti, Matteo ^h   Marike Boezen, H ⁱ   Vonk, Judith M ⁱ   Bowler, Russell ^g   Pistolesi, Massimo ^h   Puhan, Milo A ^j   Anto, Josep ^b,c,d,k   Wauters, Els ^l,m,n   Lambrechts, DIether ^l,m   Janssens, Wim ⁿ   Bigazzi, Francesca ^h   Camiciottoli, Gianna ^h   Cho, Michael H ^a   Hersh, Craig P ^a   Barnes, Kathleen ^f   Rennard, Stephen ^o,p   Boorgula, Meher Preethi ^f   Dy, Jennifer ^q   Hansel, Nadia N ^r,s   Crapo, James D ^g   Tesfaigzi, Yohannes ^e   Agusti, Alvar ^t   Silverman, Edwin K ^a,o   Garcia Aymerich, Judith ^b,c,d   more..

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^e LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

^f UNIVERSITY OF COLORADO   (United States)

^g DEPARTMENT OF MEDICINE   (United States)

^h UNIVERSITY OF FLORENCE   (Italy)

ⁱ UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^j UNIVERSITY OF ZURICH   (Switzerland)

^k HOSPITAL DEL MAR   (Spain)

^l DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^m UNIVERSITY OF LEUVEN   (Belgium)

ⁿ UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^o UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^p ASTRAZENECA   (United Kingdom)

^q NORTHEASTERN UNIVERSITY   (United States)

^r JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^s Johns Hopkins University   (United States)

^t UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BODY MASS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLUSTER ANALYSIS; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE CLASSIFICATION; DISEASE SEVERITY; EUROPE; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GENETIC HETEROGENEITY; GENETIC TRAIT; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; REPRODUCIBILITY; CLASSIFICATION; CLINICAL TRIAL; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHENOTYPE; UNITED STATES;

BODY MASS INDEX; CLUSTER ANALYSIS; EUROPE; FORCED EXPIRATORY VOLUME; HUMANS; PHENOTYPE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 85026306577     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thoraxjnl-2016-209846     Document Type: Article

References (25)

1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: Gold executive summary. Am J Respir Crit Care Med 2013;187:347-65.
2. R ennard SI, Vestbo J. The many "Small COPDs". Chest 2008;134:623-7.
3. C ho MH, Washko GR, Hoffmann TJ, et al. Cluster analysis in severe emphysema subjects using phenotype and genotype data: An exploratory investigation. Respir Res 2010;11:30.
4. Burgel PR, Paillasseur JL, Caillaud D, et al. Clinical COPD phenotypes: A novel approach using principal component and cluster analyses. Eur Respir J 2010;36:531-9.
5. Burgel PR, Paillasseur JL, Roche N. Identification of clinical phenotypes using cluster analyses in COPD patients with multiple comorbidities. Biomed Res Int 2014;2014:1-9.
6. G arcia-Aymerich J, Gómez FP, Benet M, et al. Identification and prospective validation of clinically relevant chronic obstructive pulmonary disease (COPD) subtypes. Thorax 2011;66:430-7.
7. Pistolesi M, Camiciottoli G, Paoletti M, et al. Identification of a predominant COPD phenotype in clinical practice. Respir Med 2008;102:367-76.
8. Spinaci S, Bugiani M, Arossa W, et al. A multivariate analysis of the risk in chronic obstructive lung disease (COLD). J Chronic Dis 1985;38:449-53.
9. Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2013;187:728-35.
10. Pinto LM, Alghamdi M, Benedetti A, et al. Derivation and validation of clinical phenotypes for COPD: A systematic review. Respir Res 2015;16:50.
11. R egan EA, Hokanson JE, Murphy JR, et al. Genetic epidemiology of COPD (COPDGene) study design. COPD 2010;7:32-43.
12. Vestbo J, Anderson W, Coxson HO, et al. Evaluation of COPD longitudinally to identify predictive surrogate End-points (ECLIPSE). Eur Respir J 2008;31:869-73.
13. Siebeling L, ter Riet G, van der Wal WM, et al. ICE COLD ERIC-International collaborative effort on chronic obstructive lung disease: Exacerbation risk index cohorts-study protocol for an international COPD cohort study. BMC Pulm Med 2009;9:15.
14. Scholtens S, Smidt N, Swertz MA, et al. Cohort profile: Lifelines, a three-generation cohort study and biobank. Int J Epidemiol 2015;44:1172-80.
15. Hunninghake GM, Cho MH, Tesfaigzi Y, et al. MMP12, lung function, and COPD in high-risk populations. N Engl J Med 2009;361:2599-608.
16. Wauters E, Smeets D, Coolen J, et al. The TERT-CLPTM1L locus for lung cancer predisposes to bronchial obstruction and emphysema. Eur Respir J 2011;38:924-31.
17. Buist AS, Connett JE, Miller RD, et al. Chronic obstructive pulmonary disease early intervention trial (Lung Health Study). Baseline characteristics of randomized participants. Chest 1993;103:1863-72.
18. Balcells E, Antó JM, Gea J, et al. Characteristics of patients admitted for the first time for COPD exacerbation. Respir Med 2009;103:1293-302.
19. Horvath S. Unsupervised learning with random forest predictors. J Comp Graph Stat 2012;15:118-38.
20. L angfelder P, Zhang B, Horvath S. Defining clusters from a hierarchical cluster tree: The Dynamic Tree Cut package for R. Bioinformatics 2008;24:719-20.
21. Strehl A, Ghosh J. Cluster ensembles-A knowledge reuse framework for combining multiple partitions. J Mach Learn Res 2003;3:583-617.
22. A gusti A, Bel E, Thomas M, et al. Treatable traits: Toward precision medicine of chronic airway diseases. Eur Respir J 2016;47:410-9.
23. Paoletti M, Camiciottoli G, Meoni E, et al. Explorative data analysis techniques and unsupervised clustering methods to support clinical assessment of chronic obstructive pulmonary disease (COPD) phenotypes. J Biomed Inform 2009;42:1013-21.
24. C astaldi PJ, Dy J, Ross J, et al. Cluster analysis in the COPDGene study identifies subtypes of smokers with distinct patterns of airway disease and emphysema. Thorax 2014;69:416-23.
25. T homsen M, Nordestgaard BG, Vestbo J, et al. Characteristics and outcomes of chronic obstructive pulmonary disease in never smokers in Denmark: A prospective population study. Lancet Respir Med 2013;1:543-50.